References
- Ajazuddin SS. 2010. Applications of novel drug delivery system for herbal formulations. Fitoterapia. 81:680–689.10.1016/j.fitote.2010.05.001
- Figueiredo-Rinhel ASG, Kabeya LM, Bueno PCP, Jorge-Tiossi RF, Azzolini AECS, Bastos JK, Lucisano-Valim YM. 2013. Inhibition of the human neutrophil oxidative metabolism by Baccharis dracunculifolia DC (Asteraceae) is influenced by seasonality and the ratio of caffeic acid to other phenolic compounds. J Ethnopharmacol. 150:655–664.10.1016/j.jep.2013.09.019
- Figueiredo-Rinhel ASG, Melo LL, Bortot LO, Santos EOL, Andrade MF, Azzolini AECS, Kabeya LM, Caliri A, Bastos JK, Lucisano-Valim YM. 2017. Baccharis dracunculifolia DC (Asteraceae) selectively modulates the effector functions of human neutrophils. J Pharm Pharmacol. 69:1829–1845.10.1111/jphp.2017.69.issue-12
- Landi-Librandi AP, Azzolini AECS, Oliveira CA, Lucisano-Valim YM. 2012. Inhibitory activity of liposomal flavonoids during oxidative metabolism of human neutrophils upon stimulation with immune complexes and phorbol ester. Drug Deliv. 19:177–187.10.3109/10717544.2012.679710
- Landi-Librandi AP, Chrysostomo TN, Azzolini AECS, Marzocchi-Machado CM, de Oliveira CA, Lucisano-Valim YM. 2012. Study of quercetin-loaded liposomes as potential drug carriers: in vitro evaluation of human complement activation. J Liposome Res. 22:89–99.10.3109/08982104.2011.615321
- Prasad LK, O’Mary H, Cui Z. 2015. Nanomedicine delivers promising treatments for rheumatoid arthritis. Nanomedicine. 10:2063–2074.10.2217/nnm.15.45
- Campos FR, Bressan J, Jasinski VCG, Zuccolotto T, Silva LE, Cerqueira LB. 2016. Baccharis (Asteraceae): chemical constituents and biological activities. Chem Biodivers. 13:1–17.10.1002/cbdv.v13.1
- Sousa JPB, Leite MF, Jorge RF, Resende DO, Silva-Filho AA, Furtado NAJC, Soares AEE, Spadaro ACC, Magalhães PM, Bastos JK 2011. Seasonality role on the phenolics from cultivated Baccharis dracunculifolia. Evid based complement. Alternat Med. 2011: ID 464289.